HIGHLIGHTS
- who: Christodoula Kourtidou and collaborators from the First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece have published the research: Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Markers of Vascular Damage, in the Journal: (JOURNAL)
- what: The aim of this study was to evaluate the effects of SGLT2 inhibitors on and GFR > 60 mL/min/1.73 m2 were consecutively enrolled.
SUMMARY
Sodium glucose co-transporter 2 (SGLT2) inhibitors are the antidiabetic agents of choice, along with glucagon-like peptide 1 receptor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.